eHealth raises FY2025 guidance after strong AEP; adj. EBITDA guided to $80-95M

eHealth, Inc.

Total revenue guidance raised to $540-560M from $525-565M; GAAP net income raised to $30-45M from $9-30M.
Adjusted EBITDA guidance raised to $80-95M from $60-80M; operating cash flow guided to $(25)-$0M.
AEP enrollment volume in line with last year; shift to direct branded channels improved profitability.
Q4 MA constrained LTV expected to see meaningful YoY increase driven by higher commission rates and favorable persistency.
AI screeners deployed to enhance marketing yield and sales efficiency during AEP.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

eHealth, Inc.: Adopted amended and restated bylaws changing meeting notice time zone from Pacific to Eastern, adding director nominee questionnaire process, defining 'principal competitor', clarifying insurance authorization, and other ministerial changes (effective 2025-12-16).

Change: bylaw amendment
Effective: 2025-12-16

Exact text from the filing

On December 16, 2025, in connection with a periodic review of the bylaws of eHealth, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted amended and restated bylaws (the “Amended and Restated Bylaws”), effective immediately.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

eHealth, Inc. filing history →

Source: SEC EDGAR

accession 0001333493-25-000115

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.